Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.
Publication Date
6-2019
DOI
10.1017/cts.2019.382
Publication Title
Journal of clinical and translational science
Recommended Citation
Vootukuri, S., Li, J., Nedelman, M., Thomas, C., Jiang, J.-K., Babayeva, M., & Coller, B. S. (2019). Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets. Journal of Clinical and Translational Science, 3(2–3), 65–74. https://doi.org/10.1017/cts.2019.382
